81 related articles for article (PubMed ID: 20949375)
1. Dermatological Side Effects of Cancer Treatment: Psychosocial Implications-A Systematic Review of the Literature.
Almeida V; Pires D; Silva M; Teixeira M; Teixeira RJ; Louro A; Dinis MAP; Ferreira M; Teixeira A
Healthcare (Basel); 2023 Sep; 11(19):. PubMed ID: 37830658
[TBL] [Abstract][Full Text] [Related]
2. EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines.
Nowaczyk J; Fret K; Kaminska-Winciorek G; Rudnicka L; Czuwara J
Anticancer Drugs; 2023 Sep; 34(8):942-948. PubMed ID: 36708507
[TBL] [Abstract][Full Text] [Related]
3. Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report.
Moghimi M; Khodadadi K
Case Rep Oncol; 2021; 14(2):1134-1138. PubMed ID: 34413744
[TBL] [Abstract][Full Text] [Related]
4. Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers.
Espinosa ML; Abad C; Kurtzman Y; Abdulla FR
Front Oncol; 2021; 11():605941. PubMed ID: 34123780
[TBL] [Abstract][Full Text] [Related]
5. Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer.
Werbel T; Cohen PR
Cureus; 2018 Jul; 10(7):e3056. PubMed ID: 30280054
[TBL] [Abstract][Full Text] [Related]
6. Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib.
Fukui T; Kitamura H; Harada K; Nakano H; Sawamura D
Case Rep Dermatol; 2017; 9(2):44-49. PubMed ID: 28690518
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab-Associated Flagellate Erythema: Report in a Woman with Metastatic Breast Cancer and Review of Antineoplastic Therapy-Induced Flagellate Dermatoses.
Cohen PR
Dermatol Ther (Heidelb); 2015 Dec; 5(4):253-264. PubMed ID: 26506993
[TBL] [Abstract][Full Text] [Related]
8. A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature review.
Jin F; Zhu H; Kong L; Yu J
Onco Targets Ther; 2015; 8():943-6. PubMed ID: 25960666
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis induced by trastuzumab (herceptin®).
Kim DH; Jeong NJ; Im M; Lee Y; Seo YJ; Lee JH
Ann Dermatol; 2013 May; 25(2):229-31. PubMed ID: 23717018
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of chemotherapy by anti-HER.
Kataoka A; Ishida M; Murakami S; Ohno S
Breast Cancer; 2004; 11(2):105-15. PubMed ID: 15550854
[TBL] [Abstract][Full Text] [Related]
11. The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.
Lin A; Rugo HS
Curr Treat Options Oncol; 2007 Feb; 8(1):47-60. PubMed ID: 17660958
[TBL] [Abstract][Full Text] [Related]
12. Tufted hair folliculitis in a woman treated with trastuzumab.
Rosman IS; Anadkat MJ
Target Oncol; 2010 Dec; 5(4):295-6. PubMed ID: 20949375
[TBL] [Abstract][Full Text] [Related]
13. Tufted hair folliculitis in a woman treated with lapatinib for breast cancer.
Ena P; Fadda GM; Ena L; Farris A; Santeufemia DA
Clin Exp Dermatol; 2008 Nov; 33(6):790-1. PubMed ID: 18627387
[No Abstract] [Full Text] [Related]
14. [Cutaneous side effects of EGF receptor inhibitors].
Nassar D; Soutou B; Aractingi S
Bull Cancer; 2009 Dec; 96 Suppl():S85-91. PubMed ID: 20034874
[TBL] [Abstract][Full Text] [Related]
15. Severe folliculitis with secondary impetiginization in the scalp of a woman treated with panitumumab.
Rodríguez Bandera AI; Gómez Fernández C; Vorlicka K; Ruiz-Bravo Burguillo E; Herranz Pinto P
Int J Dermatol; 2015 Jun; 54(6):e226-9. PubMed ID: 25040914
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
